RGNX
REGENXBIOCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
RGNX vs peer average
56/100
RGNX vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
FDMT is the first available peer comparator.
Small-cap gene-therapy peer useful for comparing binary clinical, regulatory, and financing risk; product and indication overlap remain limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RGNX
REGENXBIO
FDMT
4D Molecular Therapeutics
Grade
C
F
Momentum
15
39
Value
41
41
Sentiment
74
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs FDMT
RGNX / FDMT
Grade Position
In line
RGNX vs. peer average (C vs. C)
56/100
Momentum
15
FDMTValue
41
RGNXSentiment
74
RGNXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RGNX
FDMT is the first peer returned for this comparison set.